Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression of IκBα in the nucleus of human peripheral blood T lymphocytes

Abstract

According to current models the inhibitory capacity of IκBα would be mediated through the retention of Rel/NF-κB proteins in the cytosol. However, IκBα has also been detected in the nucleus of cell lines and when overexpressed by transient transfection. To gain better insight into the potential role of nuclear IκBα in a physiological context we have analysed its presence in the nucleus of human peripheral blood T lymphocytes (PBL). We demonstrate the nuclear localization of IκBα in PBL by different techniques: Western blot, indirect immunofluorescence and electron microscopy. Low levels of nuclear IκBα were detected in resting cells whereas a superinduction was obtained after PMA activation. The nuclear pool of IκBα showed a higher stability than cytosolic IκBα and was partially independent of the resynthesis of the protein. Unexpectedly, the presence of nuclear IκBα did not inhibit NF-κB binding to DNA and this phenomenon was not due to the presence of IκBβ at the nuclear level. Immunoprecipitation experiments failed to demonstrate an association between nuclear IκBα and NF-κB proteins. Our results demonstrate that in resting and PMA-activated human PBL, IκBα is present in the nucleus in an apparently inactive form unable to disrupt NF-κB binding from DNA.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alcamí J, Laín de Lera T, Folgueira L, Pedraza MA, Jacqué JM, Bachelerie F, Noriega A, Hay R, Harrich D, Gaynor R, Virelizier JL and Arenzana F. . 1995 EMBO J. 14: 1552–1560.

  • Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D and Hay RT. . 1995 Mol. Cell. Biol. 15: 2689–2696.

  • Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL and Dargemont C. . 1997 J. Cell Sci. 110: 369–378.

  • Bachelerie F, Alcamí J, Arenzana-Seisdedos F and Virelizier J-L. . 1991 Nature 350: 709–712.

  • Baeuerle PA and Henkel T. . 1994 Annu. Rev. Immunol. 12: 141–179.

  • Baeuerle PA and Baltimore D. . 1996 Cell 87: 13–20.

  • Baldwin Jr AS. . 1996 Annu. Rev. Immunol. 14: 649–683.

  • Beg A, Finco T, Nantermet P and Baldwin A. . 1993 Mol. Cell. Biol. 13: 3301–3310.

  • Beg A and Baldwin A. . 1993 Genes Dev. 7: 2064–2070.

  • Bours V, Villalobos J, Burd PR, Kelly K and Siebenlist U. . 1990 Nature 348: 76–80.

  • Cressman DE and Taub R. . 1993 Oncogene 8: 2567–2573.

  • Chen BK, Feinberg MK and Baltimore D. . 1997 J. Virol. 71: 5495–5504.

  • Dobrzanski P, Ryseck R and Bravo R. . 1993 Mol. Cell. Biol. 13: 1572–1582.

  • Finco T and Baldwin A. . 1995 Immunity 3: 263–272.

  • Fritz CC and Green MR. . 1996 Curr. Biol. 6: 848–854.

  • Fujita T, Nolan GP, Ghosh S and Baltimore D. . 1992 Genes Dev. 6: 775–787.

  • Ghosh S, Tan T-H, Rice N, Sica A and Young HA. . 1993 Proc. Natl. Acad. Sci. USA 90: 1696–1700.

  • Ghosh S, Michael JM and Kopp EB. . 1998 Annu. Rev. Immunol. 16: 225–260.

  • Harhaj EW, Maggirwar SB and Good Land Sun. . 1996 Mol. Cell. Biol. 16: 6736–6742.

  • Haskill S, Beg AA, Tompkin SM, Morris JS, Yurochko AD, Sampson-Johannes A, Mondal K, Ralph P and Baldwin AS. . 1991 Cell 65: 1281–1289.

  • Henkel T, Zabel U, Zee KV, Müller JM, Fanning E and Baeuerle PA. . 1992 Cell 68: 1121–1133.

  • Imbert V, Rupec RA, Livolsi A, Pahl HL, Britta-Mareen Traenckner E, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA and Peyron J-F. . 1996 Cell 86: 787–798.

  • Jaffray E, Wood KM and Hay RT. . 1995 Mol. Cell. Biol. 15: 2166–2172.

  • Kang S, Tran A, Grilli M and Lenardo MJ. . 1992 Science 256: 1452–1456.

  • Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeic F, Le Bail O, Urban MB, Kourilsky P, Baeuerle PA and Israël A. . 1990 Cell 62: 1007–1018.

  • Kretzschmar M, Meisterernst M, Scheidereit C, Li G and Roeder R. . 1992 Genes Dev. 6: 761–774.

  • Lai J-H and Tan T-H. . 1994 J. Biol. Chem. 259: 30077–30080.

  • Lin L, De Martino GN and Greene WC. . 1998 Cell 92: 819–823.

  • Lin YC, Brown K and Siebenlist U. . 1995 Proc. Natl. Acad. Sci. USA 92: 552–556.

  • Matthews JR, Watson EA, Buckley SL and Hay RT. . 1993 Nucleic Acids Res. 21: 4516–4523.

  • Moore NC, Girdlestone J, Anderson G, Owen JJT and Jenkison EJ. . 1995 J. Immunol. 155: 4653–4660.

  • Morin PJ and Gilmore TD. . 1992 Nucleic Acids Res. 20: 2453–2458.

  • Nakayama K, Shimizu H, Mitomo K, Watanebe T, Okamoto S and Yamamoto K. . 1992 Mol. Cell Biol. 12: 1736–1746.

  • Neri A, Chang C, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RSK and Dalla-Favera R. . 1991 Cell 67: 1075–1087.

  • Nolan GP, Ghosh S, Liou HC, Tempst P and Baltimore D. . 1991 Cell 64: 961–969.

  • Ohno H, Takimoto G and McKeithan T. . 1990 Cell 60: 991–997.

  • Perez P, Lira SA and Bravo R. . 1995 Mol. Cell. Biol. 15: 3523–3530.

  • Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR and Nabel GJ. . 1992 Proc. Natl. Acad. Sci. USA 89: 1529–1533.

  • Pimentel-Muiños FX, Mazana J and Fresno M. . 1994 J. Biol. Chem. 269: 24424–24429.

  • Pimentel-Muiños FX, Mazana J and Fresno M. . 1995 Eur. J. Immunol. 25: 179–186.

  • Rice NR, Mackichan ML and Israël A. . 1992 Cell 71: 243–253.

  • Roff M, Thompson J, Rodriguez M, Jacqué JM, Baleux F, Arenzana F and Hay RT. . 1996 Biol. Chem. 271: 7844–7850.

  • Ruben SM, Dillon PJ, Schreck R, Henkel T, Chen CH, Maher M, Baeuerle PA and Rosen CA. . 1991 Science 251: 1490–1493.

  • Suyang H, Phillips R, Douglas I and Ghosh S. . 1996 Mol. Cell. Biol. 16: 5444–5449.

  • Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P and Ghosh S. . 1995 Cell 80: 573–582.

  • Tran K, Merika M and Thanos D. . 1997 Mol. Cell. Biol. 17: 5386–5399.

  • Traenckner EBM, Wilk S and Baeuerle PA. . 1994 EMBO J. 13: 5433–5441.

  • Verma IM, Stevenson JK, Schwarz EM, VanAntwerp D and Miyamoto S. . 1995 Genes Dev. 9: 2723–2735.

  • Whiteside S, Epinat JC, Rice N and Israël A. . 1997 EMBO J. 16: 1413–1426.

Download references

Acknowledgements

This work was supported by grants from Fondo de Investigaciones Sanitarias (94/200 and 94/1904E), Ministerio de Educación y Ciencia (SAF 96/0186), Fundación Caja de Madrid and Fundación Ramón Areces, Comunidad de Madrid, ATIRE-CNRS, Association de Recherche contre le Cancer and European Community Concerted Action (Project ROCIO). TLL was supported by Ministerio de Educación. MAP was supported by a grant from Chiron Corporation and MB by Abbott Laboratories. We would like to thank Dr R Bravo, Dr Ron T Hay and Dr N Rice for the antibodies provided. We also thank the Hematology Department for its collaboration.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laín de Lera, T., Folgueira, L., Martín, A. et al. Expression of IκBα in the nucleus of human peripheral blood T lymphocytes. Oncogene 18, 1581–1588 (1999). https://doi.org/10.1038/sj.onc.1202455

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202455

Keywords

This article is cited by

Search

Quick links